XML 22 R57.htm IDEA: XBRL DOCUMENT v2.4.1.9
Business Combinations and Contingent Consideration - Change in Fair Value of Contingent Consideration Related to Acquisitions (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2015
Talon Therapeutics, Inc. [Member]  
Change in Fair Value of Contingent Consideration [Roll Forward]  
December 31, 2014 $ 2,379sppi_BusinessAcquisitionContingentConsiderationFairValue
/ us-gaap_BusinessAcquisitionAxis
= sppi_TalonTherapeuticsMember
Fair value adjustment for the three months ended March 31, 2015 310sppi_BusinessAcquisitionContingentConsiderationAtFairValueAdjustments
/ us-gaap_BusinessAcquisitionAxis
= sppi_TalonTherapeuticsMember
March 31, 2015 2,689sppi_BusinessAcquisitionContingentConsiderationFairValue
/ us-gaap_BusinessAcquisitionAxis
= sppi_TalonTherapeuticsMember
Ligand Pharmaceuticals Inc [Member]  
Change in Fair Value of Contingent Consideration [Roll Forward]  
December 31, 2014 4,901sppi_BusinessAcquisitionContingentConsiderationFairValue
/ us-gaap_BusinessAcquisitionAxis
= sppi_LigandPharmaceuticalsIncMember
Fair value adjustment for the three months ended March 31, 2015 190sppi_BusinessAcquisitionContingentConsiderationAtFairValueAdjustments
/ us-gaap_BusinessAcquisitionAxis
= sppi_LigandPharmaceuticalsIncMember
March 31, 2015 $ 5,091sppi_BusinessAcquisitionContingentConsiderationFairValue
/ us-gaap_BusinessAcquisitionAxis
= sppi_LigandPharmaceuticalsIncMember